Serum and pituitary prolactin, LH, and FSH in androgenized female and normal male rats treated with various doses of estradiol benzoate.
D000818:Animals; D001835:Body Weight; D004305:Dose-Response Relationship, Drug; D004958:Estradiol / Q000494:pharmacology*; D004971:Estrus; D005246:Feedback; D005260:Female; D005640:Follicle Stimulating Hormone / Q000097:blood / Q000378:metabolism*; D007986:Luteinizing Hormone / Q000097:blood / Q000378:metabolism*; D008297:Male; D009929:Organ Size; D010053:Ovary / Q000254:growth & development; D010902:Pituitary Gland / Q000187:drug effects / Q000378:metabolism*; D011247:Pregnancy; D011388:Prolactin / Q000097:blood / Q000378:metabolism*; D011467:Prostate / Q000254:growth & development; D011863:Radioimmunoassay; D051381:Rats; D012669:Seminal Vesicles / Q000254:growth & development; D013739:Testosterone / Q000494:pharmacology; D014599:Uterus / Q000254:growth & development
D013739:Testosterone; D004958:Estradiol; D011388:Prolactin; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone